1-2 of 2
Julia Driessen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Clinical Trials & Observations
Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole, Craig H. Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2740–2752.
https://doi.org/10.1182/bloodadvances.2023012145
Published: 2024
Includes: Supplemental data
Journal Articles

Prognostic model using 18 F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma

Julia Driessen, Gerben J. C. Zwezerijnen, Heiko Schöder, Marie José Kersten, Alison J. Moskowitz, Craig H. Moskowitz, Jakoba J. Eertink, Martijn W. Heymans, Ronald Boellaard, Josée M. Zijlstra
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6732–6743.
https://doi.org/10.1182/bloodadvances.2023010404
Published: 2023
Includes: Supplemental data